Adenovirus siMDM2 and NDRG2 Gene Therapy Inhibits Cell Proliferation and Induces Apoptosis of Squamous Cell Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Squamous cell carcinoma (SCC) is a prevalent form of skin cancer.
• Understanding the molecular mechanisms underlying SCC progression is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the combined effects of silencing murine double minute gene 2 (MDM2) and overexpressing N-myc downstream-regulated gene 2 (NDRG2) on cutaneous SCC.
• To evaluate the therapeutic potential of this combined gene modulation strategy against SCC.

Main Methods:

• Utilized recombinant adenovirus vectors to deliver siMDM2 (small interfering RNA targeting MDM2) and NDRG2 expression constructs into SCC-13 cells.
• Assessed the impact of Ad-siMDM2, Ad-NDRG2, and combined Ad-siMDM2-NDRG2 infections on SCC cell proliferation in vitro.
• Evaluated tumor volume reduction and apoptosis induction in SCC-13 xenograft nude mouse models.

Main Results:

• Both Ad-siMDM2 and Ad-NDRG2 infections inhibited SCC-13 cell growth, with the combined Ad-siMDM2-NDRG2 showing the highest efficacy.
• In vivo studies demonstrated significant tumor volume reduction in mice treated with the adenovirus vectors.
• Up-regulation of apoptosis protein caspase 3 was observed across all treatment groups, indicating induction of programmed cell death.

Conclusions:

• Adenovirus-mediated simultaneous silencing of MDM2 and overexpression of NDRG2 synergistically inhibits SCC cell proliferation and induces apoptosis.
• This combined gene therapy approach shows potential for preventing SCC growth and metastasis, offering a promising therapeutic strategy.